<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2013-05-29" modified="2021-06-02" version="29">
<accession>K7WDL7</accession>
<name>IRIS_CATRO</name>
<protein>
<recommendedName>
<fullName evidence="7">(S)-8-oxocitronellyl enol synthase</fullName>
<ecNumber evidence="1 2 3 4">1.3.1.122</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="6">Iridoid synthase</fullName>
<shortName evidence="6">ISY</shortName>
</alternativeName>
</protein>
<organism>
<name type="scientific">Catharanthus roseus</name>
<name type="common">Madagascar periwinkle</name>
<name type="synonym">Vinca rosea</name>
<dbReference type="NCBI Taxonomy" id="4058"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Viridiplantae</taxon>
<taxon>Streptophyta</taxon>
<taxon>Embryophyta</taxon>
<taxon>Tracheophyta</taxon>
<taxon>Spermatophyta</taxon>
<taxon>Magnoliopsida</taxon>
<taxon>eudicotyledons</taxon>
<taxon>Gunneridae</taxon>
<taxon>Pentapetalae</taxon>
<taxon>asterids</taxon>
<taxon>lamiids</taxon>
<taxon>Gentianales</taxon>
<taxon>Apocynaceae</taxon>
<taxon>Rauvolfioideae</taxon>
<taxon>Vinceae</taxon>
<taxon>Catharanthinae</taxon>
<taxon>Catharanthus</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2012" name="Nature" volume="492" first="138" last="142">
<title>An alternative route to cyclic terpenes by reductive cyclization in iridoid biosynthesis.</title>
<authorList>
<person name="Geu-Flores F."/>
<person name="Sherden N.H."/>
<person name="Courdavault V."/>
<person name="Burlat V."/>
<person name="Glenn W.S."/>
<person name="Wu C."/>
<person name="Nims E."/>
<person name="Cui Y."/>
<person name="O'Connor S.E."/>
</authorList>
<dbReference type="PubMed" id="23172143"/>
<dbReference type="DOI" id="10.1038/nature11692"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2019" name="Nat. Chem. Biol." volume="15" first="71" last="79">
<title>Uncoupled activation and cyclization in catmint reductive terpenoid biosynthesis.</title>
<authorList>
<person name="Lichman B.R."/>
<person name="Kamileen M.O."/>
<person name="Titchiner G.R."/>
<person name="Saalbach G."/>
<person name="Stevenson C.E.M."/>
<person name="Lawson D.M."/>
<person name="O'Connor S.E."/>
</authorList>
<dbReference type="PubMed" id="30531909"/>
<dbReference type="DOI" id="10.1038/s41589-018-0185-2"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2015" name="Angew. Chem. Int. Ed. Engl." volume="54" first="15478" last="15482">
<title>Structures of iridoid synthase from Cantharanthus roseus with bound NAD(+), NADPH, or NAD(+)/10-oxogeranial: reaction mechanisms.</title>
<authorList>
<person name="Hu Y."/>
<person name="Liu W."/>
<person name="Malwal S.R."/>
<person name="Zheng Y."/>
<person name="Feng X."/>
<person name="Ko T.P."/>
<person name="Chen C.C."/>
<person name="Xu Z."/>
<person name="Liu M."/>
<person name="Han X."/>
<person name="Gao J."/>
<person name="Oldfield E."/>
<person name="Guo R.T."/>
</authorList>
<dbReference type="PubMed" id="26768532"/>
<dbReference type="DOI" id="10.1002/anie.201508310"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 26-388 IN COMPLEX WITH NADP AND SUBSTRATE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVE SITES</scope>
<scope>MUTAGENESIS OF LYS-146; PHE-149; TYR-178; PHE-342; ALA-346 AND SER-349</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2016" name="J. Struct. Biol." volume="194" first="224" last="230">
<title>Structure of iridoid synthase in complex with NADP(+)/8-oxogeranial reveals the structural basis of its substrate specificity.</title>
<authorList>
<person name="Qin L."/>
<person name="Zhu Y."/>
<person name="Ding Z."/>
<person name="Zhang X."/>
<person name="Ye S."/>
<person name="Zhang R."/>
</authorList>
<dbReference type="PubMed" id="26868105"/>
<dbReference type="DOI" id="10.1016/j.jsb.2016.02.010"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 26-388 IN COMPLEX WITH NADP AND SUBSTRATE</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2016" name="Nat. Chem. Biol." volume="12" first="6" last="8">
<title>Structural determinants of reductive terpene cyclization in iridoid biosynthesis.</title>
<authorList>
<person name="Kries H."/>
<person name="Caputi L."/>
<person name="Stevenson C.E.M."/>
<person name="Kamileen M.O."/>
<person name="Sherden N.H."/>
<person name="Geu-Flores F."/>
<person name="Lawson D.M."/>
<person name="O'Connor S.E."/>
</authorList>
<dbReference type="PubMed" id="26551396"/>
<dbReference type="DOI" id="10.1038/nchembio.1955"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) OF 23-388 IN COMPLEX WITH NADP</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
</reference>
<comment type="function">
<text evidence="1 5">Iridoid synthase that catalyzes the first step in generation of the iridoid ring scaffold using the linear monoterpene (6E)-8-oxogeranial as substrate. Iridoids comprise a large family of distinctive bicyclic monoterpenes that possess a wide range of pharmacological activities, including anticancer, anti-inflammatory, antifungal and antibacterial activities.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="1 3 4 5">
<text>(S)-8-oxocitronellyl enol + NADP(+) = (6E)-8-oxogeranial + H(+) + NADPH</text>
<dbReference type="Rhea" id="RHEA:62592"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:57783"/>
<dbReference type="ChEBI" id="CHEBI:58349"/>
<dbReference type="ChEBI" id="CHEBI:64239"/>
<dbReference type="ChEBI" id="CHEBI:144481"/>
<dbReference type="EC" id="1.3.1.122"/>
</reaction>
<physiologicalReaction direction="right-to-left" evidence="1 3 4 5">
<dbReference type="Rhea" id="RHEA:62594"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="1 3 4 5">
<text>(S)-8-oxocitronellyl enol + NAD(+) = (6E)-8-oxogeranial + H(+) + NADH</text>
<dbReference type="Rhea" id="RHEA:62596"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:57945"/>
<dbReference type="ChEBI" id="CHEBI:64239"/>
<dbReference type="ChEBI" id="CHEBI:144481"/>
<dbReference type="EC" id="1.3.1.122"/>
</reaction>
<physiologicalReaction direction="right-to-left" evidence="1 3 4 5">
<dbReference type="Rhea" id="RHEA:62598"/>
</physiologicalReaction>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="1">4.5 uM for (6E)-8-oxogeranial</KM>
<KM evidence="4">10.6 uM for (6E)-8-oxogeranial</KM>
<KM evidence="1">4.7 uM for NADPH</KM>
<text>kcat is 1.6 sec(-1) with (6E)-8-oxogeranial. kcat is 2.2 sec(-1) with NADPH.</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="1 2 3 4">Homodimer.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-16184393">
<id>K7WDL7</id>
</interactant>
<interactant intactId="EBI-16184393">
<id>K7WDL7</id>
<label>-</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Cytoplasm</location>
<location evidence="1">Cytosol</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="1">Expressed in internal phloem-associated parenchyma (IPAP) cells.</text>
</comment>
<comment type="similarity">
<text evidence="7">Belongs to the short-chain dehydrogenases/reductases (SDR) family. Highly divergent.</text>
</comment>
<comment type="caution">
<text evidence="5 8">Was originally thought to catalyze the entire reaction from (6E)-8-oxogeranial to nepetalactol including a cyclase step (PubMed:23172143). New results have shown that the cyclase is a different enzyme and this enzyme exclusively catalyzes a reduction step (PubMed:30531909).</text>
</comment>
<dbReference type="EC" id="1.3.1.122" evidence="1 2 3 4"/>
<dbReference type="EMBL" id="JX974564">
<property type="protein sequence ID" value="AFW98981.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PDB" id="5COA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20 A"/>
<property type="chains" value="A/B=26-388"/>
</dbReference>
<dbReference type="PDB" id="5COB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65 A"/>
<property type="chains" value="A/B/C/D=26-388"/>
</dbReference>
<dbReference type="PDB" id="5DBF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00 A"/>
<property type="chains" value="A/B=26-388"/>
</dbReference>
<dbReference type="PDB" id="5DBG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95 A"/>
<property type="chains" value="A/B=26-388"/>
</dbReference>
<dbReference type="PDB" id="5DBI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20 A"/>
<property type="chains" value="A/B=26-388"/>
</dbReference>
<dbReference type="PDB" id="5DCU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40 A"/>
<property type="chains" value="A/B=23-388"/>
</dbReference>
<dbReference type="PDB" id="5DCW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90 A"/>
<property type="chains" value="A=23-388"/>
</dbReference>
<dbReference type="PDB" id="5DCY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45 A"/>
<property type="chains" value="A/B=23-388"/>
</dbReference>
<dbReference type="PDB" id="5DF1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75 A"/>
<property type="chains" value="A/B=23-388"/>
</dbReference>
<dbReference type="PDB" id="5EMH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10 A"/>
<property type="chains" value="A=21-388"/>
</dbReference>
<dbReference type="PDBsum" id="5COA"/>
<dbReference type="PDBsum" id="5COB"/>
<dbReference type="PDBsum" id="5DBF"/>
<dbReference type="PDBsum" id="5DBG"/>
<dbReference type="PDBsum" id="5DBI"/>
<dbReference type="PDBsum" id="5DCU"/>
<dbReference type="PDBsum" id="5DCW"/>
<dbReference type="PDBsum" id="5DCY"/>
<dbReference type="PDBsum" id="5DF1"/>
<dbReference type="PDBsum" id="5EMH"/>
<dbReference type="SMR" id="K7WDL7"/>
<dbReference type="DIP" id="DIP-62000N"/>
<dbReference type="PRIDE" id="K7WDL7"/>
<dbReference type="KEGG" id="ag:AFW98981"/>
<dbReference type="BioCyc" id="MetaCyc:MONOMER-20521"/>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0016628">
<property type="term" value="F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016099">
<property type="term" value="P:monoterpenoid biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR036291">
<property type="entry name" value="NAD(P)-bd_dom_sf"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF51735">
<property type="entry name" value="SSF51735"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0521">NADP</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<feature type="chain" description="(S)-8-oxocitronellyl enol synthase" id="PRO_0000422594">
<location>
<begin position="1"/>
<end position="388"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NADP" evidence="2 3 4 9 10 12">
<location>
<begin position="38"/>
<end position="40"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NADP" evidence="2 3 4 9 10 12">
<location>
<begin position="66"/>
<end position="67"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NADP" evidence="2 3 4 9 10 12">
<location>
<begin position="84"/>
<end position="85"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NADP" evidence="2 3 4 9 10 12">
<location>
<begin position="108"/>
<end position="109"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NADP" evidence="2 3 4 9 10 12">
<location>
<begin position="211"/>
<end position="213"/>
</location>
</feature>
<feature type="active site" evidence="3">
<location>
<position position="146"/>
</location>
</feature>
<feature type="active site" evidence="3">
<location>
<position position="178"/>
</location>
</feature>
<feature type="binding site" description="NADP" evidence="2 3 4 9 10 12">
<location>
<position position="142"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="3 11">
<location>
<position position="146"/>
</location>
</feature>
<feature type="binding site" description="NADP" evidence="2 3 4 9 10 12">
<location>
<position position="178"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="3 4 9 11">
<location>
<position position="178"/>
</location>
</feature>
<feature type="binding site" description="NADP; via amide nitrogen" evidence="2 3 4 9 10 12">
<location>
<position position="204"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="3 4 9">
<location>
<position position="349"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces enzymatic activity 6-fold." evidence="3">
<original>K</original>
<variation>A</variation>
<location>
<position position="146"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly reduces enzymatic activity." evidence="3">
<original>F</original>
<variation>M</variation>
<location>
<position position="149"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzymatic activity." evidence="3">
<original>Y</original>
<variation>A</variation>
<variation>F</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzymatic activity." evidence="3">
<original>F</original>
<variation>A</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on enzymatic activity." evidence="3">
<original>A</original>
<variation>I</variation>
<location>
<position position="346"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on enzymatic activity." evidence="3">
<original>S</original>
<variation>F</variation>
<location>
<position position="349"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="29"/>
<end position="36"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="42"/>
<end position="48"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="51"/>
<end position="54"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="58"/>
<end position="67"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="71"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="88"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="103"/>
<end position="106"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="111"/>
<end position="113"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="115"/>
<end position="129"/>
</location>
</feature>
<feature type="turn" evidence="15">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="138"/>
<end position="142"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="146"/>
<end position="149"/>
</location>
</feature>
<feature type="turn" evidence="16">
<location>
<begin position="153"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="177"/>
<end position="191"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="195"/>
<end position="201"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="203"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="215"/>
<end position="228"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="239"/>
<end position="243"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="248"/>
<end position="250"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="251"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="265"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="270"/>
<end position="274"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="282"/>
<end position="293"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="309"/>
<end position="313"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="317"/>
<end position="327"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="334"/>
<end position="337"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="340"/>
<end position="346"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="357"/>
<end position="361"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="370"/>
<end position="383"/>
</location>
</feature>
<evidence key="1" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23172143"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26551396"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26768532"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26868105"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30531909"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="30531909"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000305"/>
<evidence key="8" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="23172143"/>
</source>
</evidence>
<evidence key="9" type="ECO:0007744">
<source>
<dbReference type="PDB" id="5COB"/>
</source>
</evidence>
<evidence key="10" type="ECO:0007744">
<source>
<dbReference type="PDB" id="5DBF"/>
</source>
</evidence>
<evidence key="11" type="ECO:0007744">
<source>
<dbReference type="PDB" id="5DBI"/>
</source>
</evidence>
<evidence key="12" type="ECO:0007744">
<source>
<dbReference type="PDB" id="5DF1"/>
</source>
</evidence>
<evidence key="13" type="ECO:0007829">
<source>
<dbReference type="PDB" id="5COA"/>
</source>
</evidence>
<evidence key="14" type="ECO:0007829">
<source>
<dbReference type="PDB" id="5COB"/>
</source>
</evidence>
<evidence key="15" type="ECO:0007829">
<source>
<dbReference type="PDB" id="5DCU"/>
</source>
</evidence>
<evidence key="16" type="ECO:0007829">
<source>
<dbReference type="PDB" id="5DCY"/>
</source>
</evidence>
<evidence key="17" type="ECO:0007829">
<source>
<dbReference type="PDB" id="5DF1"/>
</source>
</evidence>
<sequence length="388" mass="43850" checksum="906C11AD93A04E76" modified="2013-02-06" version="1">MSWWWKRSIGAGKNLPNQNKENGVCKSYKSVALVVGVTGIVGSSLAEVLKLPDTPGGPWKVYGVARRPCPVWLAKKPVEYIQCDVSDNQETISKLSPLKDITHIFYVSWIGSEDCQTNATMFKNILNSVIPNASNLQHVCLQTGIKHYFGIFEEGSKVVPHDSPFTEDLPRLNVPNFYHDLEDILYEETGKNNLTWSVHRPALVFGFSPCSMMNIVSTLCVYATICKHENKALVYPGSKNSWNCYADAVDADLVAEHEIWAAVDPKAKNQVLNCNNGDVFKWKHIWKKLAEEFGIEMVGYVEGKEQVSLAELMKDKDQVWDEIVKKNNLVPTKLKEIAAFWFADIAFCSENLISSMNKSKELGFLGFRNSMKSFVSCIDKMRDYRFIP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>